645 related articles for article (PubMed ID: 32151332)
1. Molecular and clinical epidemiology of carbapenem-resistant Enterobacterales in the USA (CRACKLE-2): a prospective cohort study.
van Duin D; Arias CA; Komarow L; Chen L; Hanson BM; Weston G; Cober E; Garner OB; Jacob JT; Satlin MJ; Fries BC; Garcia-Diaz J; Doi Y; Dhar S; Kaye KS; Earley M; Hujer AM; Hujer KM; Domitrovic TN; Shropshire WC; Dinh A; Manca C; Luterbach CL; Wang M; Paterson DL; Banerjee R; Patel R; Evans S; Hill C; Arias R; Chambers HF; Fowler VG; Kreiswirth BN; Bonomo RA;
Lancet Infect Dis; 2020 Jun; 20(6):731-741. PubMed ID: 32151332
[TBL] [Abstract][Full Text] [Related]
2. Molecular epidemiology of carbapenem-resistant Enterobacterales in Thailand, 2016-2018.
Paveenkittiporn W; Lyman M; Biedron C; Chea N; Bunthi C; Kolwaite A; Janejai N
Antimicrob Resist Infect Control; 2021 Jun; 10(1):88. PubMed ID: 34090537
[TBL] [Abstract][Full Text] [Related]
3. Meropenem-Vaborbactam Activity against Carbapenem-Resistant
Castanheira M; Doyle TB; Kantro V; Mendes RE; Shortridge D
Antimicrob Agents Chemother; 2020 Jan; 64(2):. PubMed ID: 31712207
[TBL] [Abstract][Full Text] [Related]
4. Risk factors for acquisition of carbapenemase-producing versus non-carbapenemase-producing enterobacterales: a case-control study.
Hassoun-Kheir N; Hussein K; Karram M; Saffuri M; Badaan S; Peleg S; de Kraker MEA; Aboelhega W; Warman S; Alon T; Eluk O; Geffen Y; Paul M
Clin Microbiol Infect; 2023 May; 29(5):629-634. PubMed ID: 36641053
[TBL] [Abstract][Full Text] [Related]
5. Clinical outcomes and bacterial characteristics of carbapenem-resistant Klebsiella pneumoniae complex among patients from different global regions (CRACKLE-2): a prospective, multicentre, cohort study.
Wang M; Earley M; Chen L; Hanson BM; Yu Y; Liu Z; Salcedo S; Cober E; Li L; Kanj SS; Gao H; Munita JM; Ordoñez K; Weston G; Satlin MJ; Valderrama-Beltrán SL; Marimuthu K; Stryjewski ME; Komarow L; Luterbach C; Marshall SH; Rudin SD; Manca C; Paterson DL; Reyes J; Villegas MV; Evans S; Hill C; Arias R; Baum K; Fries BC; Doi Y; Patel R; Kreiswirth BN; Bonomo RA; Chambers HF; Fowler VG; Arias CA; van Duin D;
Lancet Infect Dis; 2022 Mar; 22(3):401-412. PubMed ID: 34767753
[TBL] [Abstract][Full Text] [Related]
6. Comparing mortality in patients with carbapenemase-producing carbapenem resistant Enterobacterales and non-carbapenemase-producing carbapenem resistant Enterobacterales bacteremia.
Hovan MR; Narayanan N; Cedarbaum V; Bhowmick T; Kirn TJ
Diagn Microbiol Infect Dis; 2021 Dec; 101(4):115505. PubMed ID: 34399381
[TBL] [Abstract][Full Text] [Related]
7. Carbapenem-Resistant enterobacterales in individuals with and without health care risk factors -Emerging infections program, United States, 2012-2015.
Bulens SN; Reses HE; Ansari UA; Grass JE; Carmon C; Albrecht V; Lawsin A; McAllister G; Daniels J; Lee YK; Yi S; See I; Jacob JT; Bower CW; Wilson L; Vaeth E; Lynfield R; Vagnone PS; Shaw KM; Dumyati G; Tsay R; Phipps EC; Bamberg W; Janelle SJ; Beldavs ZG; Cassidy PM; Kainer M; Muleta D; Mounsey JT; Laufer-Halpin A; Karlsson M; Lutgring JD; Walters MS
Am J Infect Control; 2023 Jan; 51(1):70-77. PubMed ID: 35909003
[TBL] [Abstract][Full Text] [Related]
8. Investigation on the transmission rate of carbapenemase-producing carbapenem-resistant Enterobacterales among exposed persons in a tertiary hospital using whole-genome sequencing.
Chang E; Chang HE; Shin IS; Oh YR; Kang CK; Choe PG; Park WB; Choi EH; Oh MD; Park KU; Kim NJ
J Hosp Infect; 2022 Jun; 124():1-8. PubMed ID: 35307505
[TBL] [Abstract][Full Text] [Related]
9. Characteristics of community-acquired carbapenem-resistant Enterobacterales.
Shrestha R; Luterbach CL; Dai W; Komarow L; Earley M; Weston G; Herc E; Jacob JT; Salata R; Wong D; Anderson D; Rydell KB; Arias CA; Chen L; van Duin D;
J Antimicrob Chemother; 2022 Sep; 77(10):2763-2771. PubMed ID: 36179278
[TBL] [Abstract][Full Text] [Related]
10. Molecular characterization of carbapenem-resistant
Yan WJ; Jing N; Wang SM; Xu JH; Yuan YH; Zhang Q; Li AL; Chen LH; Zhang JF; Ma B; Ma Q; Li Y
J Med Microbiol; 2021 Mar; 70(3):. PubMed ID: 33587030
[No Abstract] [Full Text] [Related]
11. Incidence of a subsequent carbapenem-resistant Enterobacteriaceae infection after previous colonisation or infection: a prospective cohort study.
Tang SSL; Chee E; Teo JQ; Chlebicki MP; Kwa ALH
Int J Antimicrob Agents; 2021 Jun; 57(6):106340. PubMed ID: 33857538
[TBL] [Abstract][Full Text] [Related]
12. Molecular Epidemiology of Carbapenem-Resistant Enterobacterales Strains Isolated from Blood Cultures in Antalya, Turkey.
Su HR; Turhan Ö; Erman Daloğlu CA; Öğünç MD; Özhak B; Öngüt G; Kuşkucu MA; Midilli K; Mamıkoğlu L
Lab Med; 2020 Nov; 51(6):601-605. PubMed ID: 32383446
[TBL] [Abstract][Full Text] [Related]
13. Molecular characteristics of carbapenemase-producing Enterobacterales in the Netherlands; results of the 2014-2018 national laboratory surveillance.
van der Zwaluw K; Witteveen S; Wielders L; van Santen M; Landman F; de Haan A; Schouls LM; Bosch T;
Clin Microbiol Infect; 2020 Oct; 26(10):1412.e7-1412.e12. PubMed ID: 32006688
[TBL] [Abstract][Full Text] [Related]
14. Epidemiology of multidrug-resistant Enterobacteriaceae in Sri Lanka: First evidence of bla
Kumudunie WGM; Wijesooriya LI; Namalie KD; Sunil-Chandra NP; Wijayasinghe YS
J Infect Public Health; 2020 Sep; 13(9):1330-1335. PubMed ID: 32439355
[TBL] [Abstract][Full Text] [Related]
15. Multicenter study on the prevalence of colonization due to carbapenem-resistant
Fasciana T; Antonelli A; Bianco G; Lombardo D; Codda G; Roscetto E; Perez M; Lipari D; Arrigo I; Galia E; Tricoli MR; Calvo M; Niccolai C; Morecchiato F; Errico G; Stefani S; Cavallo R; Marchese A; Catania MR; Ambretti S; Rossolini GM; Pantosti A; Palamara AT; Sabbatucci M; Serra N; Giammanco A
Front Public Health; 2023; 11():1270924. PubMed ID: 38186699
[TBL] [Abstract][Full Text] [Related]
16. Early OXA-48-Producing
Gijón D; Tedim AP; Valverde A; Rodríguez I; Morosini MI; Coque TM; Manrique M; Pareja E; Tobes R; Ruiz-Garbajosa P; Cantón R
mSphere; 2020 Apr; 5(2):. PubMed ID: 32269151
[TBL] [Abstract][Full Text] [Related]
17. Carbapenem-resistant Enterobacteriaceae in patients with bacteraemia at tertiary hospitals in South Africa, 2015 to 2018.
Perovic O; Ismail H; Quan V; Bamford C; Nana T; Chibabhai V; Bhola P; Ramjathan P; Swe Swe-Han K; Wadula J; Whitelaw A; Smith M; Mbelle N; Singh-Moodley A;
Eur J Clin Microbiol Infect Dis; 2020 Jul; 39(7):1287-1294. PubMed ID: 32124106
[TBL] [Abstract][Full Text] [Related]
18. mCIM test as a reliable assay for the detection of CRE in the Gulf region.
Al Musawi S; Ur Rahman J; Aljaroodi SA; AlShammari L; Itbaileh A; Mohammed H; Saeed N; Abdalhamid B; Alkharsah KR; Aljindan RY
J Med Microbiol; 2021 Jul; 70(7):. PubMed ID: 34232118
[No Abstract] [Full Text] [Related]
19. Poor outcomes in both infection and colonization with carbapenem-resistant Enterobacterales.
Howard-Anderson JR; Earley M; Komarow L; Abbo L; Anderson DJ; Gallagher JC; Grant M; Kim A; Bonomo RA; van Duin D; Muñoz-Price LS; Jacob JT;
Infect Control Hosp Epidemiol; 2022 Dec; 43(12):1840-1846. PubMed ID: 35105408
[TBL] [Abstract][Full Text] [Related]
20. Risk Factors and Molecular Epidemiology of Complicated Intra-Abdominal Infections With Carbapenem-Resistant Enterobacteriaceae: A Multicenter Study in China.
Liu J; Zhang L; Pan J; Huang M; Li Y; Zhang H; Wang R; Zhao M; Li B; Liu L; Gong Y; Bian J; Li X; Tang Y; Lei M; Chen D
J Infect Dis; 2020 Mar; 221(Suppl 2):S156-S163. PubMed ID: 32176797
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
